General Practice Doctors in Daytona Beach, FL Accepting Medicare

8 General Practice doctors found. Showing 1 - 8

Mrs. Luz M Alicea Berrios, MD General Practice Medicare: Medicare Enrolled Practice Location: 1425 Dunn Ave, Daytona Beach, FL 32114 Phone: 386-323-9600    Fax: 386-323-9695

Dr. Loretha King, DO General Practice Medicare: Not Enrolled in Medicare Practice Location: 143 Executive Cir, Daytona Beach, FL 32114 Phone: 772-233-9515

Dr. Monica Edith Cantu, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 1890 Lpga Blvd Ste 130, Primecare At Twin Lakes, Daytona Beach, FL 32117 Phone: 386-274-2212    Fax: 386-274-1508

Dr. Cesar Arturo Calderon, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 3950 Tiger Bay Rd, Tomoka Correctional Institution Medical Dept, Daytona Beach, FL 32124 Phone: 386-323-1120    Fax: 386-323-1168

Dr. Milton Mendez, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 3950 Tiger Bay Road, Medical Department Tomoka Correctional Institution, Daytona Beach, FL 32124 Phone: 386-323-1141    Fax: 386-323-1168

Dr. Angel Emanuel Benitez, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 1425 Dunn Ave, Daytona Beach, FL 32114 Phone: 386-323-9600

Dr. Ronald Dean Lippmann, D.O. General Practice Medicare: Medicare Enrolled Practice Location: 2381 Mason Ave, Ste 100, Daytona Beach, FL 32117 Phone: 321-207-9029    Fax: 844-410-7960

Dr. Evan Demetrios Carratt, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 1243 S Ridgewood Ave, Daytona Beach, FL 32114 Phone: 386-252-2504

News Archive

Idera Pharmaceuticals to discuss TLR-targeted drug discovery and development programs

Idera Pharmaceuticals, Inc., a biotechnology company engaged in the discovery and development of DNA- and RNA-based drug candidates targeted to Toll-like Receptors (TLR), today announced that it will discuss its TLR-targeted drug discovery and development programs and provide a general corporate overview at the UBS Global Life Sciences Conference on Monday, September 21, 2009, at 10:30 a.m. EDT at the Grand Hyatt New York Hotel in New York City.

First whole-genome survey of where three commonly used retroviruses into human DNA

Retroviruses are one of the most common vehicles for delivering therapeutic payloads via gene therapy in animal models of disease and human patients.

Amgen's biosimilar Phase 3 rheumatoid arthritis study meets primary and secondary endpoints

Amgen today announced a Phase 3 study evaluating the efficacy and safety of biosimilar candidate ABP 501 compared with Humira® (adalimumab) in patients with moderate-to-severe rheumatoid arthritis met its primary and key secondary endpoints.

Socio-ecological and cultural factors attributed to later stage cancer diagnosis

Researchers from the Keck School of Medicine of the University of Southern California (USC) found that patients who received a later stage cancer diagnosis were likely to be living in an unsafe neighborhood, using public transportation and traveling at least 45 minutes to get to a doctor's office.

New guideline released to improve diagnosis, care for people with prolonged disorders of consciousness

For people in a vegetative or minimally conscious state caused by brain injury, an accurate diagnosis and ongoing medical and rehabilitative care based on the latest scientific evidence could mean a better chance for recovery, according to a new guideline by the American Academy of Neurology, American Congress of Rehabilitation Medicine and the National Institute on Disability, Independent Living, and Rehabilitation Research.

Read more Medical News

› Verified 9 days ago